Vincerx Pharma, Inc. (VINC)
OTCMKTS · Delayed Price · Currency is USD
0.0128
0.00 (0.00%)
At close: Feb 12, 2026

Vincerx Pharma Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
4.444.9912.7811.66111.4661.79
Short-Term Investments
---40.8--
Cash & Short-Term Investments
4.444.9912.7852.46111.4661.79
Cash Growth
-13.17%-60.98%-75.63%-52.93%80.38%-
Other Receivables
-1.041.041.37--
Receivables
-1.041.041.37--
Prepaid Expenses
0.120.090.050.130.181.1
Restricted Cash
0.080.080.070.070.11-
Other Current Assets
0.040.210.781.930.10.21
Total Current Assets
4.696.4114.7355.96111.8463.11
Property, Plant & Equipment
--2.333.244.18-
Other Long-Term Assets
-1.61.160.081.650.08
Total Assets
4.698.0118.2259.29117.6863.19
Accounts Payable
2.272.032.54.072.020.49
Accrued Expenses
0.353.241.763.924.725
Current Portion of Leases
--1.161.020.74-
Other Current Liabilities
-0.010.190.146.4532.32
Total Current Liabilities
2.625.285.619.1613.9237.81
Long-Term Leases
--1.342.413.44-
Other Long-Term Liabilities
--0.050.05--
Total Liabilities
2.625.28711.6217.3637.81
Common Stock
0--000
Additional Paid-In Capital
196.08191.79170.33166.65156.3142.04
Retained Earnings
-194.19-189.19-159.11-118.96-55.97-16.67
Comprehensive Income & Other
0.170.120.01-0.03-0.02-
Shareholders' Equity
2.072.7211.2247.67100.3225.38
Total Liabilities & Equity
4.698.0118.2259.29117.6863.19
Total Debt
--2.53.444.17-
Net Cash (Debt)
4.444.9910.2849.02107.2961.79
Net Cash Growth
53.48%-51.49%-79.03%-54.31%73.62%-
Net Cash Per Share
1.762.639.6546.62124.92235.31
Filing Date Shares Outstanding
5.235.231.071.061.050.7
Total Common Shares Outstanding
5.232.241.071.061.050.7
Working Capital
2.071.139.1346.8197.9225.3
Book Value Per Share
0.391.2210.4844.8895.2836.30
Tangible Book Value
2.072.7211.2247.67100.3225.38
Tangible Book Value Per Share
0.391.2210.4844.8895.2836.30
Machinery
--0.260.260.26-
Source: S&P Global Market Intelligence. Standard template. Financial Sources.